Joaquim Vives (ORCID: 0000-0001-9719-5235) is a Biochemist, MSci in Biotechnology and PhD in Biochemistry (Universitat Autònoma de Barcelona, Spain) with extensive experience in the R&D biotech sector, both in private and academic environments, where he focused on the optimisation of cellular processes towards i) high yield production of diagnostic and therapeutic molecules, and ii) the development of methods to manufacture cells for drug screening and therapy, in compliance with pharmaceutical quality standards. Dr. Vives conducted post-doctoral research at the Institute for Stem Cell Research (University of Edinburgh, UK) in 2003, then moved to Stem Cell Sciences Ltd (Cambridge, UK) in 2006, and joined Banc de Sang i Teixits (Barcelona, Spain) in 2008, where he leads a Research Group focusing on the Development of Advanced Therapy Medicinal Products, focusing on i) Scale-up production of clinical grade cells in bioreactors (e.g., Biochem Eng J 159, 107601); ii) generation of 3D tissue constructs (e.g., JTERM 12 (1), e532); iii) development of in vivo models of osteochondral regeneration (e.g., Histol&Histopathol 36, 19); and iv) identification and validation of biomarkers of bone remodelling (e.g., Bone Reports 16, 101157).
Dr. Vives is inventor of 3 patents, published 50+ articles, and supervised 8 successful PhD students. He is associated to the “Musculoskeletal Tissue Engineering Group” (Vall d'Hebron Institut de Recerca, Barcelona, Spain), and teaches at the UAB Faculty of Medicine as associated lecturer, where he coordinates the Official master's degree in Transfusion Medicine and Cellular and Tissue Therapies, a joint degree with Leiden University Medical Centre (LUMC, The Netherlands) and the recently granted ASIA-TRANSMED Erasmus+ for improving professionals’ competencies in transfusion medicine to make blood transfusion safer and more efficient, while improving harmonisation. He is actively engaged with scientific communication initiatives (e.g., TEDx speaker https://youtu.be/qfV5IxdLpSg) and served to scientific societies, including roles such as: treasurer at the International Society for Cell and Gene Therapy (ISCT) European Regional Executive Committee (2020-2023 term), editorial board member of Cytotherapy (2023-2026 term) and ISCT’s Telegraft Newsletter (since 2020), coordinator of the European Society for the Advancement of Cell Technology (ESACT) Bioprocessing and Manufacturing of Gene and Cell Therapy Products Annual Course.
Dr. Vives is inventor of 3 patents, published 50+ articles, and supervised 8 successful PhD students. He is associated to the “Musculoskeletal Tissue Engineering Group” (Vall d'Hebron Institut de Recerca, Barcelona, Spain), and teaches at the UAB Faculty of Medicine as associated lecturer, where he coordinates the Official master's degree in Transfusion Medicine and Cellular and Tissue Therapies, a joint degree with Leiden University Medical Centre (LUMC, The Netherlands) and the recently granted ASIA-TRANSMED Erasmus+ for improving professionals’ competencies in transfusion medicine to make blood transfusion safer and more efficient, while improving harmonisation. He is actively engaged with scientific communication initiatives (e.g., TEDx speaker https://youtu.be/qfV5IxdLpSg) and served to scientific societies, including roles such as: treasurer at the International Society for Cell and Gene Therapy (ISCT) European Regional Executive Committee (2020-2023 term), editorial board member of Cytotherapy (2023-2026 term) and ISCT’s Telegraft Newsletter (since 2020), coordinator of the European Society for the Advancement of Cell Technology (ESACT) Bioprocessing and Manufacturing of Gene and Cell Therapy Products Annual Course.